Back to Authors

Klingbiel, Dirk

0000-0002-9914-0243

Mayo Clinic

Bristol-Myers Squibb (Switzerland)

Citations 2

OT04 | GOLSEEK‐1: A PHASE 3, DOUBLE‐BLIND, RANDOMIZED STUDY OF GOLCADOMIDE + R‐CHOP VERSUS PLACEBO + R‐CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK, LARGE B‐CELL LYMPHOMA
Nowakowski, Grzegorz S. , Bouzani, Maria, Kwiatek, M., Berkovits, Alejandro, Gkasiamis, Argyrios, Patel, Amar , Boucaud, Floriane, Petel, Adrien , Hoffmann, Marc Steven , Muñoz, Javier , Westin, Jason R. , Jurczak, Wojciech , Huang, Tien‐Shang , Klingbiel, Dirk , Vassilakopoulos, Theodoros P.

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70093_ot04 Get It

Prognostic impact of deficient mismatch repair (dMMR) in 7,803 stage II/III colon cancer (CC) patients (pts): A pooled individual pt data analysis of 17 adjuvant trials in the ACCENT database.
Thibodeau, Stephen N. , Gallinger, Steven , Monges, Geneviève, Pogue–Geile, Katherine L. , Roth, Arnaud, Pavey, Emily S., Kim, George P., Group, ACCENT Collaborative, Sargent, Daniel J. , Shi, Qian , Yothers, Greg , Tejpar, Sabine , Bertagnolli, Monica M. , André, Thierry , Labianca, Roberto , Hamilton, Stanley R. , Paik, Soonmyung , Klingbiel, Dirk , Sinicrope, Frank A. , Group, ACCENT Collaborative

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3507-3507

10.1200/jco.2014.32.15_suppl.3507 Get It